Homepage
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
Fibrosis Disease: From Mechanisms and Therapeutic Targets to Animal Models
Learn about WuXi Biology’s integrated platform to support fibrosis drug development
White Paper: Streamlining Gene Therapy with AAVs
In our latest white paper, critical considerations for a successful AAV discovery and development pipeline are discussed.
On-Demand Webinar: Strategies to Accelerate the Development of Antibody-Drug Conjugates
Learn about strategies for evaluating ADC efficacy, resistance, and immunogenicity that address both antibody-specific and payload-specific mechanisms
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by nearly 3000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Latest Poster
On-bead DEL Application and Case Study for Drug...
On-bead DEL Application and Case Study for Drug Discovery
VIEW PosterLatest Poster
Accelerating CIP Discovery with ASMS and DEL
Accelerating CIP Discovery with ASMS and DEL
VIEW PosterLatest Poster
Discovery of a Novel Covalent Inhibitor Using DEL
Discovery of a Novel Covalent Inhibitor Using DEL
VIEW PosterLatest Publication
DEL Screening to Discover Small Molecule Ligands for...
DEL Screening to Discover Small Molecule Ligands for RNA
VIEW PublicationLatest Publication
Targeting FAK Improves the Tumor Uptake of ADCs
Targeting FAK Improves the Tumor Uptake of ADCs
VIEW PublicationLatest Publication
Discovery of a Selective BET Inhibitor for Treating...
Selective BET Inhibitor for Treating Osteoarthritis
VIEW PublicationLatest Poster
Production and Characterization of Protein Biologics
Production and Characterization of Protein Biologics
VIEW PosterLatest Publication
Discovery of GuaB Inhibitors for the Treatment of...
Small molecule GuaB inhibitors that are potent against MTB
VIEW PublicationLatest Publication
Small Molecule Reactivator of p53 Y220C Mutant
Small-Molecule Reactivator of p53 Y220C Mutant
VIEW PublicationLatest Presentation
BaF3 Models Carrying HER2 Mutations
BaF3 Models Carrying HER2 Mutations
VIEW Presentation